Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Mullane

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|June 1, 1990
Metastatic prostatic carcinoma presenting as cholangiocarcinoma ("Klatskin tumor")M C Chen, M R Mullane
JAMA|October 24, 1990
Serum cholesterol level and hepatomaM C Chen, M R Mullane, T E Lad
The Annals of Pharmacotherapy|July 1, 1996
Cisplatin nephrotoxicity in a patient with a single kidneyG O Udeani, K Singh, M R Mullane, et al.
Clinical Pharmacy|November 1, 1988
Morphine concentrations in plasma, ascitic fluid, and nasogastric aspirate fluid during high-dose intravenous morphine infusionP R Hutson, T J Baumann, R R Lavoie, et al.
Investigational New Drugs|January 1, 1994
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trialM R Mullane, R L Schilsky, R B Carroll, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|June 1, 1990
Metastatic prostatic carcinoma presenting as cholangiocarcinoma ("Klatskin tumor")M C Chen, M R Mullane
JAMA|October 24, 1990
Serum cholesterol level and hepatomaM C Chen, M R Mullane, T E Lad
The Annals of Pharmacotherapy|July 1, 1996
Cisplatin nephrotoxicity in a patient with a single kidneyG O Udeani, K Singh, M R Mullane, et al.
Clinical Pharmacy|November 1, 1988
Morphine concentrations in plasma, ascitic fluid, and nasogastric aspirate fluid during high-dose intravenous morphine infusionP R Hutson, T J Baumann, R R Lavoie, et al.
Investigational New Drugs|January 1, 1994
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trialM R Mullane, R L Schilsky, R B Carroll, et al.
Pageof 1